US District Court for the Northern District of West Virginia Intellectual Property Cases
Cases 11 - 20 of 118
West Virginia University Board of Governors et al v. Plasma Igniter, LLC
as 1:2021cv00116
Plaintiff:
West Virginia University Board of Governors and West Virginia University Research Corporation
Defendant:
Plasma Igniter, LLC
Cause Of Action: 28 U.S.C. § 2201
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00244
Plaintiff:
Pfizer Inc., Warner-Lambert Company LLC and PF Prism IMB B.V.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00090
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Aurobindo Pharma Ltd.
as 5:2020cv00023
Plaintiff:
Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and others
Defendant:
Aurobindo Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00019
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00101
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00097
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00037
Plaintiff:
Kaken Pharmaceutical Co., LTD., Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland LTD and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
Japan Tobacco Inc. v. Mylan Pharmaceuticals Inc.
as 1:2019cv00012
Plaintiff:
Japan Tobacco Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2018cv00226
Plaintiff:
Allergan USA, Inc., Allergan Sales, LLC, Forest Laboratories Holdings, LTD. and others
Defendant:
Sandoz Inc., Aurobindo Pharma, LTD., Mylan Pharmaceuticals Inc. and others
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
